™A single-serving powder concept
CELLURA is being developed around an individual sachet format. The 10 g figure describes the current technical dossier format; it should not be read as a substitute for final approved serving directions or label information.
What is confirmed—and what is not
The current public information describes the product concept, planned format and initial Amazon-first launch channel. Final ingredient quantities, complete excipient information, preparation directions, cautions, pricing and availability will be published when confirmed. No unapproved formulation data should be treated as the finished formula.
Ingredient disclosure
AVUNE intends to publish ingredient identity, quantity per serving, relevant extract standardisation, formulation context and research references for approved records. The public ingredient page will be updated as those details are verified and approved for disclosure.
Evidence with context
Research on an individual ingredient is not the same as evidence about the finished CELLURA formulation. AVUNE will distinguish ingredient background from product-specific evidence and will not imply clinical testing or a health outcome without appropriate substantiation.
Where to follow the launch
CELLURA is planned to launch first through Amazon. This website is currently an information and launch-update destination, not a direct checkout. The Amazon listing link will be added when the listing is live.
This article provides general educational information, not personal medical advice. It does not replace the approved label or advice from a qualified health professional.